Literature DB >> 3734804

Tetanus toxin in dissociated spinal cord cultures: long-term characterization of form and action.

W H Habig, H Bigalke, G K Bergey, E A Neale, M C Hardegree, P G Nelson.   

Abstract

The clinical course of tetanus is notable, in addition to its often dramatic clinical presentation, by the long duration of the neuromuscular symptoms. Survivors may have tetanic manifestations for several weeks after the onset of the disease. In this article we correlate the duration of specific electrophysiologic effects produced by tetanus toxin with the degradation of cell-associated toxin in primary cultures of mouse spinal cord neurons. From these studies we can conclude that the toxin has a half-life of 5-6 days. Both the heavy and the light chains of tetanus toxin degrade at similar rates. Labeled toxin, visualized by radioautography, is associated with neuronal cell bodies and neurites, and its distribution is not altered during a 1-week period following toxin exposure. Blockade of synaptic activity persists for weeks at the concentration of radiolabeled toxin used in these studies. This blockade of transmission is reversed as the toxin is degraded, suggesting that degradation of toxin may be a sufficient mechanism for recovery from tetanus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734804     DOI: 10.1111/j.1471-4159.1986.tb00700.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Restoration of exocytosis occurs after inactivation of intracellular tetanus toxin.

Authors:  F Bartels; H Bigalke
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Limited proteolysis of single-chain tetanus toxin by tissue enzymes, in cultured brain tissue and during retrograde axonal to the spinal cord.

Authors:  E Habermann; U Weller; M Hudel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

3.  Preparation of affinity-purified, biotinylated tetanus toxin, and characterization and localization of cell surface binding sites on nerve growth factor-treated PC12 cells.

Authors:  K Fujita; G Guroff; E Yavin; G Goping; R Orenberg; P Lazarovici
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

4.  A Heterologous Reporter Defines the Role of the Tetanus Toxin Interchain Disulfide in Light-Chain Translocation.

Authors:  Madison Zuverink; Chen Chen; Amanda Przedpelski; Faith C Blum; Joseph T Barbieri
Journal:  Infect Immun       Date:  2015-04-20       Impact factor: 3.441

5.  Epileptic activity outlasts disinhibition after intrahippocampal tetanus toxin in the rat.

Authors:  M A Whittington; J G Jefferys
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

6.  Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells.

Authors:  E Erdal; F Bartels; T Binscheck; G Erdmann; J Frevert; A Kistner; U Weller; J Wever; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

7.  Increased expression of GAD mRNA during the chronic epileptic syndrome due to intrahippocampal tetanus toxin.

Authors:  A Najlerahim; S F Williams; R C Pearson; J G Jefferys
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

8.  Synaptic inhibition in primary and secondary chronic epileptic foci induced by intrahippocampal tetanus toxin in the rat.

Authors:  R M Empson; J G Jefferys
Journal:  J Physiol       Date:  1993-06       Impact factor: 5.182

9.  Neuromedin s-producing neurons act as essential pacemakers in the suprachiasmatic nucleus to couple clock neurons and dictate circadian rhythms.

Authors:  Ivan T Lee; Alexander S Chang; Manabu Manandhar; Yongli Shan; Junmei Fan; Mariko Izumo; Yuichi Ikeda; Toshiyuki Motoike; Shelley Dixon; Jeffrey E Seinfeld; Joseph S Takahashi; Masashi Yanagisawa
Journal:  Neuron       Date:  2015-03-04       Impact factor: 17.173

Review 10.  Targeted secretion inhibitors-innovative protein therapeutics.

Authors:  Foster Keith; Chaddock John
Journal:  Toxins (Basel)       Date:  2010-12-03       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.